美国胃肠内镜学会指南:内镜黏膜下剥离术治疗早期食管癌和胃癌的总结与推荐
美国胃肠内镜学会(ASGE)基于GRADE框架制定本指南,针对早期食管鳞癌、食管腺癌和胃腺癌及其癌前病变,比较内镜黏膜下剥离术(ESD)与内镜黏膜切除术(EMR)和/或手术的作用,并给出推荐。
要点
- 早期食管鳞癌:>15 mm、高分化、无溃疡者建议ESD优于EMR;≤15 mm者可选择ESD或EMR。
- 早期食管腺癌:>20 mm、高分化、无溃疡者建议ESD优于EMR;≤20 mm者可选择ESD或EMR。
- 胃腺癌:20–30 mm、高/中分化、无溃疡、肠型者建议ESD优于EMR;<20 mm者可选择ESD或EMR。
核心结论
- ASGE基于GRADE框架对早期食管鳞癌、食管腺癌和胃腺癌及其癌前病变的内镜治疗给出推荐,涉及ESD与EMR和/或手术的选择。
研究设计与样本
- 美国胃肠内镜学会(ASGE)制定的临床实践指南,采用GRADE框架进行证据评价并形成推荐。
主要发现
- 早期食管鳞癌:>15 mm、高分化、无溃疡者建议ESD优于EMR;≤15 mm的类似病变建议ESD或EMR均可。
- 早期食管腺癌:>20 mm、高分化、无溃疡者建议ESD优于EMR;≤20 mm的类似病变建议ESD或EMR均可。
- 胃腺癌:20–30 mm、高或中分化、无溃疡、肠型者建议ESD优于EMR;<20 mm的类似病变建议ESD或EMR均可。
关键数值与推荐
- 食管鳞癌:对早期、高分化、无溃疡且>15 mm的病变,ASGE建议ESD优于EMR;对≤15 mm的类似病变,建议ESD或EMR均可。
- 食管鳞癌:对此类患者,ASGE建议尽可能不选择手术(建议不手术,弱推荐)。
- 食管腺癌:对早期、高分化、无溃疡且>20 mm的病变,ASGE建议ESD优于EMR;对≤20 mm的类似病变,建议ESD或EMR均可。
- 胃腺癌:对20–30 mm、高或中分化、无溃疡、肠型的早期病变,ASGE建议ESD优于EMR;对<20 mm的类似病变,建议ESD或EMR均可。
- 胃腺癌:对≤30 mm的此类病变,ASGE建议不选择手术(建议不手术,弱推荐);对低分化病变,无论大小,建议手术评估优于内镜方法(建议,弱推荐)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This clinical practice guideline from the American Society for Gastrointestinal Endoscopy (ASGE) provides an evidence-based summary and recommendations regarding the role of endoscopic submucosal dissection (ESD) in the management of early esophageal and gastric cancers. It is accompanied by the document subtitled "Methodology and Review of Evidence," which provides a detailed account of the methodology used for the evidence review. This guideline was developed using the Grading of Recommendations, Assessment, Development and Evaluation framework and specifically addresses the role of ESD versus EMR and/or surgery, where applicable, for the management of early esophageal squamous cell carcinoma (ESCC), esophageal adenocarcinoma (EAC), and gastric adenocarcinoma (GAC) and their corresponding precursor lesions. For ESCC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >15 mm, whereas in patients with similar lesions ≤15 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for such patients with ESCC, whenever possible. For EAC, the ASGE suggests ESD over EMR for patients with early-stage, well-differentiated, nonulcerated cancer >20 mm, whereas in patients with similar lesions measuring ≤20 mm, the ASGE suggests either ESD or EMR. For GAC, the ASGE suggests ESD over EMR for patients with early-stage, well- or moderately differentiated, nonulcerated intestinal type cancer measuring 20 to 30 mm, whereas for patients with similar lesions <20 mm, the ASGE suggests either ESD or EMR. The ASGE suggests against surgery for patients with such lesions measuring ≤30 mm, whereas for lesions that are poorly differentiated, regardless of size, we suggest surgical evaluation over endoscopic approaches.
引用
- Forbes N, Elhanafi SE, Al-Haddad MA, et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations. Gastrointest Endosc. 2023. PMID: 37498266. doi:10.1016/j.gie.2023.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。